Reading the Review: What a Scoping Study Can and Cannot Tell Us About the IMA
Assessing the Indian Medical Association (IMA), a 400,000-member professional organisation operating across diverse political, social and healthcare environments…
External AI tools blocked from public hospital networks over cyber safety fears
The Health Ministry blocked access this week to public AI tools on the organizational networks of public hospitals…
Israel’s HIV fight falters as at least 1 in 10 carriers may not know they are infecte
Israel lacks key data on HIV testing, is falling short of international targets and still has no comprehensive…
Anthropic launches AI drug discovery program, Claude Science
CEO of Anthropic Dario Amodei attends a working lunch with G7 leaders, G7 outreach partners and global tech…
Beechworth doctors revert to home visits for patients after taxi service left town
Not that long ago, life was good for 74-year-old Jodi Scholz who was running a small farm 10…
Calico targets longevity pathway with rare disease win
FDA Breakthrough Therapy Designation for fosigotifator highlights a mechanism that extends well beyond an ultra-rare childhood disorder. Calico…
Medicare will start covering weight-loss drugs on July 1 for the first time. Here’s what you need to know
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot…
The organ donation boom complicating the boundary between life and death
Emily Hoffman was walking home from lunch in the Pittsburgh neighborhood of Squirrel Hill in February 2023, when…
IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’ – Vertex Pharmaceuticals (NASDAQ:V
As per the recent news, Vertex Pharmaceuticals, on June 11, reported new clinical data showing that CASGEVY (exagamglogene…
Barbers bring personal grooming therapy to Kenya’s mental health hospital
NAIROBI, Kenya (AP) — At Kenya ’s largest mental health referral hospital, male patients encounter a different kind…
A pancreatic cancer drug provides new hope: Five things to know about daraxonrasib
“I don’t see it providing a cure, but it’s going to allow people to live with the disease,”…
Evommune terminates oral drug’s development in CSU
The drug failed to show any benefit in CSU patients in a Phase IIb trial. Credit: FON’s Fasai…